Aspira Pathlab & Diagnostics Limited announced audited earnings results for the fourth quarter and year ended March 31, 2020. For the quarter, the company reported sales/income from operations was INR 19.680 million compared to INR 20.771 a year ago. Total income was INR 20.369 million against INR 21.523 million a year ago. Loss after tax was INR 13.153 million against INR 12.440 million a year ago. Basic loss per share was INR 1.42 against INR 1.52 a year ago. Diluted loss per share was INR 1.53 against INR 1.78 a year ago. For the year, the company reported sales/income from operations was INR 84.164 million compared to INR 76.371 a year ago. Total income was INR 87.044 million against INR 78.903 million a year ago. Loss after tax was INR 42.406 million against INR 51.829 million a year ago. Basic loss per share was INR 4.56 against INR 6.33 a year ago. Diluted loss per share was INR 4.95 against INR 7.40 a year ago.